MEEDER ASSET MANAGEMENT INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2021$1,00068
+1033.3%
0.00%
Q2 2021$0
-100.0%
6
-99.4%
0.00%
-100.0%
Q1 2021$17,000926
+3604.0%
0.00%
Q4 2020$0
-100.0%
25
-13.8%
0.00%
Q3 2020$1,000
-66.7%
29
-84.8%
0.00%
Q1 2020$3,000
-25.0%
1910.0%0.00%
Q4 2019$4,000
+33.3%
1910.0%0.00%
Q3 2019$3,0000.0%1910.0%0.00%
Q2 2019$3,0001910.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2020
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders